Is scalene lymph node biopsy still effective ?

Year 2024, Volume: 17 Issue: 2, 50 - 53, 01.07.2024

Süleyman Emre Akın , Cem Doğan , Muhammed Samet Özdemir , Hasan Ekrem Çamaş , İsa Döngel , Rasih Yazkan

Abstract

Excision of scalene lymph nodes by surgical biopsy technique is a valuable method for the diagnosis and treatment plan of thoracic and extrathoracic malignancies and some granulomatous diseases. In this study, we aimed to investigate the efficacy and safety of scalene lymph node biopsy as a diagnostic tool. Surgical biopsy was performed in 15 patients with palpable scalene lymph nodes and their data were retrospectively analyzed. The material obtained by scalene lymph node biopsy was sufficient for 93.3% of the diagnoses. Of the diagnoses, 33.3% were non-small cell lung carcinoma metastasis, 26.7% were small cell lung carcinoma metastasis, 26.7% were lymphoma and 13.3% were non-cancer pathology. No complications were observed during or after the scalene lymph node biopsy procedure in any of the patients. Scalene lymph node biopsy is a reliable, inexpensive, and effective method for diagnosis.

Keywords

Scalene Lymph Node, Lung Cancer, Lymph Node Biopsy

Ethical Statement

The local ethics committee approval dated 29.12.2022 and decision number 25/370 was obtained from the ethics committee of Süleyman Demirel University

Supporting Institution

none

Thanks

We thank Dr. Edanur Dogan for helping analyze the data.

References

• 1. Özpolat B, Uygur ER, Şimşek S, Yazkan R, Alper M, Yücel E. Supraklaviküler Bölge Lez-yonlarının Cerrahi Tedavisi. Kırıkkale Uni Med J. 2012;14(2):12-16.
• 2. Yalçmkaya İ, Kaya ODS, Balkan ODM, Özbay B, Çetin ODG. Skalen Lenf Nodu Biyopsisi. Turkish Journal of thoracic and cardiovascular surgery. 1995;3:113-116.
• 3. Lee DH, Yonn TM, Lee JK, Lim SG et al. Supraclavicular lymph node excision biopsy in patients with suspected supraclavicular lymph node metastasis of lung cancer: Experience in a Tertiary Hospital. Chonnam Med J. 2017;53(1):69-72.
• 4. Kenney LJ, Mota C. Scalene lymph node biopsy. Henry Ford Hosp Med Bull. 1956;4(1):36-41.
• 5. Samancılar Ö, Çakan AN, Turhan K, Çağırcı U, Nart D, Özhan M. Hiler ve mediastinal lenfade-nopatilerde nonpalpabl skalen lenf düğümü bi-yopsisi sonuçları (46 olguluk bir dizi). Turkish Journal of Ecopathology. 2005;11(1):17-20.
• 6. 6 Ohno K, Utsumi T, Sasaki Y, Suzuki Y. Re-evaluation of non-palpable scalene lymph node biopsy for staging non-small cell lung cancer. Eur J Cardiothorac Surg. 2004;25(4):492-6.
• 7. Skinner DB. Scalene-lymph-node biopsy. Re-appraisal of risks and indications. N Engl J Med. 1963;268:1324-9. 8. Dong S, Zhao N, Deng W, Sun HW, Niu FY, Yang JJ, et al. Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study. World J Surg Oncol. 2017;15(1):12.
• 9. Sung YM, Lee KS, Kim BT, Kim S, Kwon OJ, Choi JY, et al. Nonpalpable supraclavicular lymph nodes in lung cancer patients: preoperative characterization with 18F-FDG PET/CT. AJR Am J Roentgenol. 2008 Jan;190(1):246-52.